Antiretroviral therapy in public and private routine health care clinics in Cameroon: Lessons from the Douala antiretroviral (DARVIR) initiative

Clinical Infectious Diseases

Volumn 41, Issue 1, 2005, Pages 108-111

  Laurent, Christian ^a,e   Meilo, Henriette ^c   Guiard Schmid, Jean Baptiste ^b   Mapouré, Yacouba ^d   Noël, Jeanne Marie ^a   M'Bangué, Madeleine ^d   Joko, Ashu ^e   Rozenbaum, Willy ^b   Ntoné, Fritz Ntoné ^d   Delaporte, Eric ^a  

^a UNIV MONTPELLIER   (France)

^b HÔPITAL TENON   (France)

^c Hopital Laquintinie   (Cameroon)

^d YAOUNDÉ GENERAL HOSPITAL   (Cameroon)

^e INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

BLOOD SAMPLING; CAMEROON; FOLLOW UP; HEALTH CENTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MEDICAL RECORD; PRIORITY JOURNAL; PRIVATE HOSPITAL; PUBLIC HEALTH SERVICE; REVIEW; VIRUS LOAD;

ACADEMIC MEDICAL CENTERS; ADULT; AMBULATORY CARE FACILITIES; ANTI-HIV AGENTS; CAMEROON; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HOSPITALS; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PRIVATE SECTOR; PROGRAM EVALUATION; PUBLIC SECTOR; TREATMENT OUTCOME; VIRAL LOAD;

EID: 20844441971     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/430712     Document Type: Review

References (14)

1. World Health Organization-Joint United Nations Programme on HIV/AIDS. Treating 3 million by 2005: making it happen. Geneva: World Health Organization, 2004. Available at: http://www.who.int/3by5/ publications/documents/en/ 3by5StrategyMakingItHappen.pdf. Accessed 12 January 2005.
2. Laurent C, Diakhaté N, Ngom Gueye NF, et al. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS 2002; 16:1363-70.
3. Laurent C, Ngom Gueye NF, Ndour CT, et al. Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. J Acquir Immune Defic Syndr 2005; 38:14-7.
4. Bourgeois A, Laurent C, Mougnutou R, et al. Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon. Antiviral Ther 2005; 10:335-41.
5. Weidle PJ, Malamba S, Mwebaze R, et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet 2002; 360:34-40.
6. Djomand G, Roels T, Ellerbrock T, et al. Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire. AIDS 2003; 17(Suppl 3):S5-15.
7. Seyler C, Anglaret X, Dakoury-Dogbo N, et al. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire. Antivir Ther 2003; 8:385-93.
8. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18:887-95.
9. Livesley N, Morris C. Antiretroviral therapy in a primary care clinic in rural South Africa. AIDS 2003; 17:2005-6.
10. Macharia DK, Chang LW, Lule G, et al. Antiretroviral therapy in the private sector of Nairobi, Kenya: a review of the experience of five physicians. AIDS 2003; 17:938-40.
11. van Oosterhout JJG, Bodasing N, Nyirenda C, Kumwenda JJ, Mallewa J, Zijlstra EE. Evaluation of the antiretroviral treatment programme at Queen Elizabeth Hospital (QECH), Blantyre, Malawi [abstract ThPeB7199]. In: Program and abstracts of the XV International AIDS Conference (Bangkok). International AIDS Society, 2004.
12. Bartlett JA, DeMasi R, Quinn J, Moxham C, Rousseau F. Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS 2001; 15:1369-77.
13. Vergne L, Malonga-Louellet G, Mistoul I, et al. Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries. J Acquir Immune Defic Syndr 2002; 29:165-8.
14. Adjé C, Cheingsong R, Roels TH, et al. High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire. J Acquir Immune Defic Syndr 2001; 26:501-6.